{"id":406421,"date":"2020-12-30T01:38:56","date_gmt":"2020-12-30T06:38:56","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=406421"},"modified":"2020-12-30T01:38:56","modified_gmt":"2020-12-30T06:38:56","slug":"cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/","title":{"rendered":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, Washington, Dec.  29, 2020  (GLOBE NEWSWIRE) &#8212; <strong>CytoDyn Inc. (OTC.QB: CYDY)<\/strong>, (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Wednesday, January 6, 2021.<\/p>\n<p>Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities:<\/p>\n<p>1) BLA submissions to Health Canada, MHRA, EMA, and US FDA<br \/>2) HIV prevention trial\/monotherapy trial<br \/>3) Potential revenue from HIV and manufacturing forecast<br \/>4) HIV Cure &#8211; amfAR<br \/>5) EUA submission timelines to same four agencies for COVID-19<br \/>6) Long-hauler clinical trial and potential data readout timelines<br \/>7) NASH trial and potential interim analysis timeline<br \/>8) Cancer trial Breakthrough Therapy designation potential timelines<br \/>9) GvHD trial status<br \/>10) Stroke\/MS new trials in 2021<br \/>11) NASDAQ uplisting status<\/p>\n<p>Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors.<\/p>\n<p>\n        <strong>Date: <\/strong> Wednesday, January 6, 2021<br \/><strong>Time:<\/strong> 1:00 pm PT \/ 4:00 pm ET<br \/><strong>Dial-In:<\/strong> None.<br \/><strong>Questions: <\/strong><\/p>\n<ul type=\"disc\">\n<li>Prior to the webcast, questions can be submitted online to <a href=\"mailto:CYDY_Team@cytodyn.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">CYDY_Team@cytodyn.com<\/a><\/li>\n<li>During the webcast, questions can be submitted through the webcast link below.<\/li>\n<\/ul>\n<p>This is a \u201clisten only\u201d webcast, which can be accessed via CytoDyn\u2019s corporate website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h9zedNiJZe496GFC9Dx_9sayuIAC4A2KragB-YKK9PlhQfPhKjAvf1Il6z_skkf_78HO03Kp1KxmsGz0IJNs4Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.cytodyn.com<\/a>\u00a0under the Investors section\/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. The webcast can also be accessed via the following link:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TmMMjauieMVL2V6bDKm-86OPKzD8COoyEcW2JkWiM52WWOF2glGlNsaYcrdyQJ4ZqNJ8CmI9-KIDjfvgLG42xnJzv8kqzzksiI8TvKAesbt9ot9ryUyJw_wVVBI7R_9qWAxTds20rC4872Y-Uy014hNpkr7XJQutPSxPfOMswal7iYj19w2BvFscr99iBFToXUs1dr6UxssbE76DIXhT_4_hJs-duS8huMxnoqbq243_3oZgiwRksyGBRDuSwkMS3jnGFan_nPEUaUOTRAmN_Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <u>https:\/\/78449.themediaframe.com\/dataconf\/productusers\/cydy\/mediaframe\/42723\/indexl.html<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until February 6, 2021.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Investors: <\/strong><br \/>\n        <br \/>Michael Mulholland<br \/>Office: 360.980.8524, ext. 102<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zoEbduPjKZCRulqKsoCFLklKMguj8uR7a1QwQpUF-GLozze2Oi5e4CitGiwpsZ89eSxNb14s53xzXOKXjUdKXBn4Wnqq3vBAsFOtEuY9lDY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mmulholland@cytodyn.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/5433283d-7250-4285-b9fb-d0f17d03d393\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Washington, Dec. 29, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Wednesday, January 6, 2021. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities: 1) BLA submissions to Health Canada, MHRA, EMA, and US FDA2) HIV prevention trial\/monotherapy trial3) Potential revenue from HIV and manufacturing forecast4) HIV Cure &#8211; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-406421","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Washington, Dec. 29, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Wednesday, January 6, 2021. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities: 1) BLA submissions to Health Canada, MHRA, EMA, and US FDA2) HIV prevention trial\/monotherapy trial3) Potential revenue from HIV and manufacturing forecast4) HIV Cure &#8211; &hellip; Continue reading &quot;CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-30T06:38:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries\",\"datePublished\":\"2020-12-30T06:38:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/\",\"name\":\"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\",\"datePublished\":\"2020-12-30T06:38:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/","og_locale":"en_US","og_type":"article","og_title":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk","og_description":"VANCOUVER, Washington, Dec. 29, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Wednesday, January 6, 2021. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities: 1) BLA submissions to Health Canada, MHRA, EMA, and US FDA2) HIV prevention trial\/monotherapy trial3) Potential revenue from HIV and manufacturing forecast4) HIV Cure &#8211; &hellip; Continue reading \"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-30T06:38:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries","datePublished":"2020-12-30T06:38:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/","name":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=","datePublished":"2020-12-30T06:38:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODcxMSMzODk5NDUyIzIwMjY1OTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-january-6-to-provide-timelines-for-clinical-and-regulatory-developments-submission-of-4-hiv-blas-and-eua-requests-for-covid-in-different-countries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=406421"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406421\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=406421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=406421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=406421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}